Review ArticlesThe Current Status of Tissue-Engineered Vascular GraftsJaspan, Vita N.; Hines, George L. MDAuthor Information From the Division of Vascular Surgery, Department of Thoracic and Cardiovascular Surgery, Winthrop University Hospital, Mineola, NY. The authors declare no conflict of interest in the preparation of this manuscript. Correspondence: George L. Hines, MD, Winthrop Cardiovascular Associates, 120 Mineola Blvd, Suite 300, Mineola NY 11501. E-mail: email@example.com. Cardiology in Review: September/October 2015 - Volume 23 - Issue 5 - p 236-239 doi: 10.1097/CRD.0000000000000060 Buy Metrics Abstract Tissue-engineered vascular grafts (TEVGs) are currently being developed to overcome the limitations and complications associated with traditional synthetic grafts. This article aims to review the current status of research into the production and use of tissue-engineered grafts. TEVGs have a number of theoretical advantages over synthetic grafts. The results of animal and human studies have been promising, but more work must be done before TEVGs can replace traditional grafts. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.